10-K: 1606 Corp. Reports Increased Net Loss in 2024 Amid Shift to AI Chatbot Business

1606 Corp. reported a significant increase in net loss for 2024, driven by higher operating expenses, as the company transitions its focus to AI chatbot technology.

Summary

• 1606 Corp., formerly focused on hemp products, is now concentrating on AI chatbot technology, particularly for the CBD industry and public companies.
• The company's net loss increased to $4,514,971 in 2024 from $1,580,733 in 2023, primarily due to a rise in operating expenses, including stock-based compensation.
• Revenue from CBD product sales increased to $7,195 in 2024 from $1,603 in 2023, but the company is discontinuing this business.
• Operating expenses rose significantly from $1,620,580 in 2023 to $4,138,157 in 2024, largely due to $3 million in stock-based compensation.
• The company's auditors have raised substantial doubt about its ability to continue as a going concern, citing its history of losses and dependence on raising capital.
• To continue operations for the next 12 months, the company estimates a cash need of approximately $1,000,000, which it plans to meet through increased revenue or external financing.
• The company identified material weaknesses in its internal control over financial reporting, including a lack of a functioning audit committee and inadequate segregation of duties.
• Austen Lambrecht was appointed as the new CEO in July 2024, replacing Greg Lambrecht.
• The company terminated an LOI to acquire a minority equity position in Adnexus, an AI biotech company, though discussions are ongoing.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to increased losses, going concern doubts, and internal control weaknesses, despite the potential of the AI chatbot market.

Positives

• The company is transitioning to the AI chatbot market, which is projected to reach $2.25 trillion by 2030.
• Revenue from CBD product sales increased to $7,195 in 2024 from $1,603 in 2023.
• The company has cultivated considerable interest in its AI Chatbot technology through its website, online ads, and email campaigns.
• The company is using independent sales organizations (ISOs) to sell the Chatbot or include it in a package deal with their products.

Negatives

• The company reported a net loss of $4,514,971 for the year ended December 31, 2024.
• The company's auditors have raised substantial doubt about its ability to continue as a going concern.
• The company identified material weaknesses in its internal control over financial reporting.
• The company is discontinuing its CBD product sales business.
• The company terminated an LOI to acquire a minority equity position in Adnexus, an AI biotech company, though discussions are ongoing.

Risks

• The company has yet to achieve profitable operations and is dependent on its ability to raise capital.
• The company faces substantial capital requirements and an absence of liquidity.
• The company faces intense competition in the AI chatbot market.
• The company's assets have a limited history and a history of operating losses.
• The company's ability to attract and retain qualified employees is a risk.
• The company's ability to execute its strategy is a risk.
• Compliance with government regulation and legal liabilities is a risk.
• A breach of customers' data could negatively materially affect the company's public trust and could result in loss of customers and revenue.

Future Outlook

The company plans to focus on expanding its AI chatbot technology beyond the CBD industry to other consumer-facing industries and will need to raise capital to sustain operations.

Management Comments

• Management believes the assumptions made to carve out the Company's underlying standalone financial statements from the consolidated Singlepoint results prior to the April 2021 spin-off are reasonable.
• Management will continue to pursue additional equity financing through private placements of the Company's common stock.

Industry Context

The company is attempting to capitalize on the growth in the artificial intelligence and CBD markets by providing AI chatbot solutions tailored to the CBD industry and public companies.

Comparison to Industry Standards

• The document does not provide enough information to compare the company's results to specific industry standards or comparable companies.
• Without detailed financial metrics and industry benchmarks, it is difficult to assess the company's performance relative to its peers.

Management Changes

Corporate Governance

Related Party Transactions

• During the year ended December 31, 2024, a total of 4,040,000 shares of Class A convertible preferred stock was issued to the members of the Company's Board of Directors for services provided.
• During the year ended December 31, 2024, a total of 90 shares of Series B super voting preferred stock was issued to the Company's Chief Executive Officer, Austen Lambrecht, and to the Company's former Chief Executive Officer, Greg Lambrecht as Compensation for Services.
• During the year ended December 31, 2024, the Company borrowed $415,000 in a series of cash payments from the Company's former CEO and shareholder in exchange for the issuance of a promissory note.

Stakeholder Impact

• Shareholders face increased risk due to the company's financial instability and going concern doubts.
• Employees may be affected by potential cost-cutting measures or restructuring due to the company's financial challenges.
• Customers may experience changes in service or product offerings as the company shifts its business focus.

Next Steps

• The company will focus on expanding its AI chatbot technology to other industries.
• The company will need to raise capital to sustain operations.
• The company will work to address the material weaknesses in its internal control over financial reporting.

Key Dates

Keywords

AI Chatbot, Artificial Intelligence, CBD, Financial Results, 10-K, Operating Loss, Net Loss, Going Concern, Internal Control, Revenue